Lexicon announces exclusive licensing agreement with viatris for sotagliflozin in all markets outside of the u.s. and europe

-lexicon to receive an upfront payment of $25 million and the potential for contingent regulatory and commercial milestone payments -lexicon to receive an upfront payment of $25 million and the potential for contingent regulatory and commercial milestone payments
VTRS Ratings Summary
VTRS Quant Ranking